Kyle Carver

Kyle Carver

Chief Financial OfficeratEvommune· In proxies 2024–2025

Pay in FY2025+256% from the year before

Kyle Carver was paid $4.4M in FY2025 (Dec), up 256%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Evommune proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. EvommunePublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?